MALVERN, Pa., July 12, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today ...
The bankruptcy path addresses Endo’s more than $8 billion debt and establishes a “pathway to closure” with all the lawsuits it has been fight “at an unsustainable cost,” CEO Blaise Coleman said.
Endo entered into a restructuring support agreement with holders of more than a majority of its first lien debt on a sale transaction that would substantially reduce outstanding indebtedness, address ...
Endo shared that it has taken an important step toward concluding its financial restructuring process by filing a proposed Plan of Reorganization and related Disclosure Statement with the U.S.
(RTTNews) - Endo International plc (ENDP) said Tuesday that the company and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results